Hebrew University and Yissum Developing Novel Technology Platform for 3D Printing Personalized Medicine

IMTS

Share this Article

Yissum, which is the Hebrew University of Jerusalem‘s technology transfer company and handles the patenting and commercialization of any inventions produced there, has had a hand in many unique 3D printing innovations, such as Nano Dimension’s conductive nano-inks and a process to generate hybrid machine elements. Last year, the company, which was founded in 1964 and has licensed over 900 technologies and registered over 10,000 patents covering 2,800 inventions, introduced a novel technology platform for 3D printing personalized food, and has now moved on to 3D printing personalized medicine.

The company, which is only the third of its kind, builds a bridge between academic research and its worldwide community of entrepreneurs, investors, and industry. It’s responsible for spinning more than 135 total companies. Yissum recently announced a novel technology platform for fabricating 3D printed drug capsules, and presented it today at the university’s 2nd annual 3D Printing and Beyond conference, which is sponsored by Yissum, the university, and the Jerusalem Development Authority.

Professor Shlomo Magdassi, head of the university’s 3D and Functional Printing Center and a member of the Center for Nanoscience and Nanotechnology and Institute of Chemistry, worked with Dr. Ofra Benny, a researcher at the university’s Institute for Drug Research, to develop the innovative drug 3D printing technology platform.

“Professor Magdassi and Dr. Benny’s research is an excellent example of the  kind of interdisciplinary transformational inventions that originate  from the Hebrew University,” said Dr. Yaron Daniely, CEO and President of Yissum. “This technology is bringing us closer to a future in which the medical field can offer personalized, patient-centered care.”

The technology is based on custom 3D printed hydrogels with delayed release characteristics, and allows for a complex design of drug delivery systems that is not currently available in the more traditional pharmaceutical manufacturing techniques.

Dr. Magdassi already has plenty of experience with 3D printed hydrogels and other unique 3D printable materials. 3D hydrogels are hydrophilic polymeric networks that are cross-linked by either chemical covalent bonds, physical interactions, or a combination. Because of these crosslinks between polymer chains and their hydrophilic nature, hydrogels can actually swell up to a hundred times, or even a thousand, of their dried mass without needing to be dissolved in water, and they are an ideal material for biomedical applications.

Yissum’s company mission is to take transformational technologies and innovations and convert them into commercial solutions that address the most urgent challenges in our world, in order to benefit society. I’d say this new 3D printing platform fits the bill – the approach makes it possible to 3D print customized medications out of hydrogel objects that can change shape, expand, and even activate on a delayed schedule.

The novel new 3D printing platform can not only achieve complex release profiles and structures of drugs, but it can also personalize prescription medicines, so doctors can more accurately tailor the dosage levels and exposure of medications for different patients. Thanks to 3D printing, medication may not have to be one-size-fits-all.

Professor Magdassi and Dr. Benny presented their work at the 3D Printing and Beyond conference today, which Professor Magdassi helps organize with Dr. Michael Layani. The conference brings together a range of researchers and industry leaders from around the world to discuss and learn more about the latest advances in defense-related technologies, electronics, and pharmaceuticals, in addition to 3D printed innovations like automotive parts and food.

Discuss this story and other 3D printing topics at 3DPrintBoard.com or share your thoughts in the Facebook comments below. 

Share this Article


Recent News

3D Printing Webinar and Event Roundup: March 3, 2024

3D Printing News Briefs, March 2, 2024: 3D Printed Firearms, FDA Clearance, & More



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

3D Printing News Unpeeled: Fatigue Strength, Electrochemical Transistors and Anycubic Hack

KTH Royal Institute of Technology along with Stockholm University has made electrochemical transistors using a Nanoscribe 3D printer. This may allow them to relatively easily make small scale and custom...

AddUp Announces Deputy CEO & Innovations in Medical & Injection Molding AM

Global metal 3D printer OEM AddUp, a joint venture between French tire giant Michelin and Paris-based industrial engineering corporation Fives, appointed Julien Marcilly as its new CEO at the end...

Daring AM: The Global Crackdown on 3D Printed Firearms Continues

In the last few years, a surge in police raids uncovering 3D printed guns has led to concerns about their growing association with criminal gangs. Although typically seen as inferior...

3D Printing Webinar and Event Roundup: February 25, 2024

It’s another busy week of webinars and events in the AM industry, including Silicone Expo Europe in Amsterdam, an open house for Massivit in North America, and the AM for...